Your SlideShare is downloading. ×
  • Like
Management of the Infertile Couple in a Primary Care Setting. Part I
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×

Now you can save presentations on your phone or tablet

Available for both IPhone and Android

Text the download link to your phone

Standard text messaging rates apply

Management of the Infertile Couple in a Primary Care Setting. Part I

  • 84 views
Published

This is intended for primary care physicians. It is a 2 part presentation that begins with gynecologic cancer screening and ends with the evaluation and management of the infertile couple

This is intended for primary care physicians. It is a 2 part presentation that begins with gynecologic cancer screening and ends with the evaluation and management of the infertile couple

Published in Health & Medicine
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
No Downloads

Views

Total Views
84
On SlideShare
0
From Embeds
0
Number of Embeds
2

Actions

Shares
Downloads
4
Comments
0
Likes
1

Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
    No notes for slide

Transcript

  • 1. MANAGEMENT OF THE INFERTILE COUPLE IN A PRIMARY CARE SETTING PART ONE MILIE NWOYE MD SHAPE ARMY MEDICAL CLINIC FEBRUARY 20TH 2014
  • 2. OUTLINE • GENERAL GYNECOLOGY • Gynecologic cancer screening • Pre-conception counselling • Tests for ovarian reserve • THE INFERTILE COUPLE • Definition • Evaluating the infertile couple • Managing the infertile couple (PART 1)
  • 3. CERVICAL CANCER SCREENING • Screening starts at age 21 regardless of sex initiation • Ages 21-29: Pap test only every 3 years • Ages 30-65: Pap test every 3 years OR Pap and high risk HPV testing every 5 years • Women without a cervix: No Pap test required except less than 20 year history of high grade abnormality OR history of DES in-utero exposure
  • 4. Population Recommended Screening Method Women younger than 21 years No screening Women aged 21–29 years Cytology alone every 3 years Women aged 30–65 years Human papillomavirus and cytology co-testing (preferred) every 5 years Comment Screening by HPV testing alone is not recommended Cytology alone (acceptable) every 3 years Women older than 65 years No screening is necessary after adequate negative prior screening results Women with a history of CIN 2, CIN 3 or adenocarcinoma in situ should continue routine age-based screening for at least 20 years Women who underwent total hysterectomy No screening is necessary Applies to women without a cervix and without a history of CIN 2, CIN 3, adenocarcinoma in situ, or cancer in the past 20 years Practice bulletin, ACOG, November 2012
  • 5. BREAST CANCER SCREENING • Mammography has a false negative rate of 20%* • Age <40: Self breast awareness • Age >40: Self breast awareness, annual clinical breast exam and mammogram (except women with first degree relatives with premenopausal breast cancer OR women with BRCA mutation) ACOG guidelines *National Cancer Institute
  • 6. Mammography American College of Obstetricians and Gynecologists Age 40 years and older annually Clinical Breast Examination Age 20-39 years every 1-3 years Breast SelfExamination Instruction Consider for highrisk patients Breast SelfAwareness Recommended Age 40 years and older annually Practice Bulletin, ACOG, August 2011
  • 7. ENDOMETRIAL CANCER SCREENING • Most common gynecologic cancer Risk Factor Relative Risk • No screening tool. Longterm high dose HRT 10-20 • Red flags: postmenopausal bleeding Tamoxifen 3-7 • Diagnosis: PCOS or estrogen producing tumor >5 • Endometrial biopsy or D&C Obesity 2-5 • Transvaginal ultrasound Nulliparity 3 ACOG practice bulletin, August 2005
  • 8. OVARIAN CANCER SCREENING • Lifetime risk of 1/70 • No evidence that screening leads to earlier detection or improved survival • Diagnostic tests: CA 125 and transvaginal ultrasound ACOG, July 2007
  • 9. PRE-CONCEPTION SCREENING • Folic acid 0.4mg (or 4mg with a history of open neural tube defects) • Risk factor-based genetic screening/ counselling • Optimize medical conditions (HTN, DM) • Domestic violence screening • Avoid alcohol, tobacco, radiation, and illegal drugs • Weight reduction • Vaccinations (Rubella, influenza) ACOG Committee opinion, 9/2005
  • 10. TESTING FOR OVARIAN RESERVE • ASRM, 2005 Speroff, 2005
  • 11. THE INFERTILE COUPLE DEFINITION For women ≤ 35: No conception after 1 year of unprotected intercourse For women >35: No conception after 6 months of unprotected intercourse Only 43% seek medical care Age (years) Infertility rates (%) 15-24 4 25-34 13 35-44 30 Age and infertility. Science 1986;233:1389-94
  • 12. CAUSES OF INFERTILITY- COUPLES 5% 10% 35% 15% Tubal and pelvic pathlogy Male factor Ovulatory dysfunction Unexplained Unusual problems 35% Speroff, 2005
  • 13. CAUSES OF FEMALE INFERTILITY 10% 10% 40% Ovulatory dysfunction Tubal and pelvic disease Unexplained Unusual problems 40% Speroff, 2005
  • 14. STANDARD FERTILITY WORK-UP • Assessment of male factor infertility: semen analysis • Assessment of ovulation: history, BBT, day 21 progesterone • Assessment of uterus/endometrium and ovaries: transvaginal ultrasound • Assessment of tubal patency: hysterosalpingogram or laparoscopy • Assessment of endometriosis: laparoscopy ASRM Fact sheet 2005
  • 15. INFERTILITY MANAGEMENT • Timed intercourse • Ovulation induction • Intrauterine insemination (+/- ovulation induction) • In-vitro fertilization (IVF) • Intracytoplasmic sperm injection (ICSI)